O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.39%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$10.3B
AUM Growth
+$10.3B
(+13%)
Cap. Flow
+$348M
Cap. Flow
% of AUM
3.38%
Top 10 Holdings %
Top 10 Hldgs %
36.86%
Holding
137
New
10
Increased
53
Reduced
17
Closed
11
Top Buys
| 1 |
Biogen
BIIB
|
$103M |
| 2 |
SIEN
Sientra, Inc.
SIEN
|
$53.5M |
| 3 |
TSRO
TESARO, Inc.
TSRO
|
$49.5M |
| 4 |
MGLN
Magellan Health Services, Inc.
MGLN
|
$48.3M |
| 5 |
Gilead Sciences
GILD
|
$45.9M |
Top Sells
| 1 |
CFN
CAREFUSION CORPORATION
CFN
|
$215M |
| 2 |
Arrowhead Research
ARWR
|
$76.5M |
| 3 |
STJ
St Jude Medical
STJ
|
$55.3M |
| 4 |
QGENF
QIAGEN NV
QGENF
|
$38.7M |
| 5 |
OraSure Technologies
OSUR
|
$34.4M |
Sector Composition
| 1 | Healthcare | 87.22% |
| 2 | Financials | 0.08% |
| 3 | Technology | 0.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Biogen
BIIB
$19.4B
| $507M | 4.85% | 1,494,700 +304,600 | +26% | +$103M |
|
2
Bristol-Myers Squibb
BMY
$96B
| $454M | 4.34% | 7,688,700 +396,700 | +5% | +$23.4M |
|
3
Amgen
AMGN
$155B
| $431M | 4.12% | 2,708,000 +105,000 | +4% | +$16.7M |
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $409M | 3.91% | 3,657,600 +329,600 | +10% | +$36.9M |
|
|
5
Gilead Sciences
GILD
$140B
| $401M | 3.83% | 4,249,500 +487,300 | +13% | +$45.9M |
|
|
AGN
6
DELISTED
Allergan plc
AGN
| $383M | 3.66% | 1,488,200 +52,000 | +4% | +$13.4M |
|
7
AbbVie
ABBV
$372B
| $349M | 3.33% | 5,331,100 -146,900 | -3% | -$9.61M |
|
8
HCA Healthcare
HCA
$94.5B
| $316M | 3.02% | 4,308,000 +95,000 | +2% | +$6.97M |
|
|
RLYP
9
DELISTED
RELYPSA INC COM
RLYP
| $273M | 2.61% | 8,857,551 | – | – |
|
10
Illumina
ILMN
$15.8B
| $273M | 2.6% | 1,476,600 +133,600 | +10% | +$24.7M |
|
|
SHPG
11
DELISTED
Shire pic
SHPG
| $249M | 2.38% | 1,170,000 -49,000 | -4% | -$10.4M |
|
12
Intuitive Surgical
ISRG
$170B
| $233M | 2.22% | 440,000 +53,600 | +14% | +$28.4M |
|
|
ICPT
13
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $232M | 2.21% | 1,485,000 | – | – |
|
14
Incyte
INCY
$16.5B
| $230M | 2.2% | 3,149,300 -105,600 | -3% | -$7.72M |
|
|
MDVN
15
DELISTED
MEDIVATION, INC.
MDVN
| $226M | 2.16% | 2,268,900 -4,100 | -0.2% | -$408K |
|
|
IPXL
16
DELISTED
Impax Laboratories, Inc.
IPXL
| $212M | 2.02% | 6,678,000 +272,800 | +4% | +$8.64M |
|
17
Perrigo
PRGO
$3.27B
| $209M | 1.99% | 1,247,800 +103,100 | +9% | +$17.2M |
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $206M | 1.97% | 1,731,200 +381,200 | +28% | +$45.3M |
|
19
Thermo Fisher Scientific
TMO
$186B
| $200M | 1.91% | 1,595,700 -95,700 | -6% | -$12M |
|
|
HNT
20
DELISTED
HEALTH NET INC
HNT
| $199M | 1.9% | 3,711,400 +641,000 | +21% | +$34.3M |
|
21
Cooper Companies
COO
$13.4B
| $198M | 1.89% | 1,220,600 +77,900 | +7% | +$12.6M |
|
|
ESRX
22
DELISTED
Express Scripts Holding Company
ESRX
| $195M | 1.87% | 2,307,000 +209,000 | +10% | +$17.7M |
|
23
Molina Healthcare
MOH
$9.8B
| $192M | 1.83% | 3,581,900 +844,000 | +31% | +$45.2M |
|
24
Ironwood Pharmaceuticals
IRWD
$214M
| $184M | 1.76% | 12,012,100 | – | – |
|
25
Agilent Technologies
A
$35.7B
| $166M | 1.58% | 4,051,000 -248,000 | -6% | -$10.2M |
|